|
|
Texas
Pharmacy Business Council is an organization of
American Pharmacies and the Academy of Independent
Pharmacists-Texas. www.TxRxCouncil.org
|
|
Five Star
PharmacyPhriends |
|
* Sen.
Robert Deuell, MD (R-Greenville) : Rx
discount card regulation
* Rep. Dan
Gattis (R-Georgetown): mail order
parity * Rep.
Yvonne Gonzalez-Toureilles (D-Alice): PBM
regulation, prompt pay, Rx discount card
regulation, transparency in state PBM contracts,
and mail order parity *
Sen.
Glenn Hegar Jr. (R-Katy): transparency in
state PBM contracts * Rep.
Chuck Hopson, RPh (D-Jacksonville): PBM
transparency and prompt pay
* Rep.
Todd Hunter (R-Corpus Christi): prompt
pay * Rep.
Carl Isett (R-Lubbock): PBM
regulation * Rep.
Lois Kolkhorst (R-Brenham) : transparency
in state PBM
contracts Rep.
Sid Miller (R-Stephenville): PBM
regulation, transparency in state PBM
contracts * Sen.
Jane Nelson (R-Flower Mound): transparency
in state PBM contracts, mail order parity, and
mail order pharmacy audit *
Sen.
Leticia Van de Putte, RPh (D-San
Antonio)
Four
Star
PharmacyPhriends
* Rep. Bill
Callegari (R-Katy): PBM regulation and
prompt pay * Rep. Bryan
Hughes (R-Mineola): PBM regulation and
prompt pay * Rep. Eddie Lucio
III (D-Brownsville): PBM
regulation * Sen. Kirk
Watson (D-Austin): mail order
parity
Three Star
PharmacyPhriends *
Rep. Alma
Allen (D-Houston): PBM
regulation * Rep. Roberto
Alonzo (D-Dallas): PBM
regulation * Rep. Ellen
Cohen (D Houston): PBM
regulation * Rep. Byron
Cook (R-Corsicanna): transparency in state
PBM contracts and mail order
parity * Rep. John
Davis (R-Houston): transparency in state
PBM contracts * Rep. Allen
Fletcher (R-Tomball): PBM regulation and
prompt pay * Rep. Dan Flynn
(R-Van): mail order parity *
Rep. Stephen
Frost (D-Atlanta): PBM
regulation * Rep. Linda
Harper-Brown (R-Irving): PBM
regulation * Rep. Mark
Homer (D-Paris): transparency in state PBM
contracts * Rep. Bryan
Hughes (R-Mineola): PBM
regulation * Rep. Marisa
Marquez (D-El Paso): PBM
regulation * Rep. Solomon Ortiz
Jr. (D-Corpus Christi) : PBM regulation and
prompt pay * Rep. David
Swinford (R-Dumas): transparency in state
PBM
contracts |
|
We need your
"any time" phone number
|
Can we count on
you? We need your "any time" number so we can call
when a crucial vote pops up and we need you to
take action.
Click here to send us your
contact info, including a phone number that rings
directly to you. This information will NOT be
given to anyone and will be kept private. We will
use it only if we have an urgent need to reach
you.
Our effectiveness
is only as good as our members' willingness to get
involved.
|
|
Texas legislation success
list |
REGULATION
OF Rx DISCOUNT CARDS
PBM
TRANSPARENCY IN STATE CONTRACTS
|
| |

|
Community
pharmacy scores well in Baucus health care reform
bill
|
If there
has been any discussion in the news media about
pharmacy, it's been limited to PhRMA. The
pharmacist, especially independent pharmacists,
has not garnered coverage, as far as I can tell.
But that's OK, because the National Community
Pharmacists Association has been busy behind the
scenes and has scored some points for our
team.
NCPA staff met last week with staff
at the Health and Human Services Office of Health
Reform to lay out key priorities for the health
care reform bill. The Administration will
obviously have a "seat at the table" when
developing a final bill so NCPA continues to
meet with HHS and White House staff to relay key
priorities, according to NCPA Senior Vice
President, Government Affairs John Coster, PhD,
RPh.
This is a significant accomplishment
for community pharmacy. Coupled with our
recent approval of the Texas Medicaid fee
increase, it demonstrates what pharmacists can
accomplish when they get active and make their
voice heard by public policy makers. This
legislative process is far from over and we must
remain vigilant to keep the items important to
pharmacy in the final bill.
For
community pharmacy, the health care reform bill
presented last week by Sen. Max Baucus (D-MT.),
chairman of the Senate Finance Committee, is a
better bill than the House version discussed
during Congress' August recess.
Medicaid reimbursement,
AMP and AWP Under the proposed
Baucus bill, AMP would more closely reflect prices
paid by retail pharmacies, and the FUL for
generics would be set at no less than 175 percent
of the weighted average AMP for the product. This
is in contrast to the language in the House bill,
which sets the FUL at 130 percent of the weighted
average AMP.
NCPA met last week with the
senior counselor staff of the Secretary of the
Department of Health and Human Services to discuss
both AMP- and AWP-related issues. NCPA explained
our concerns with the AMP regulation proposed by
the agency in 2007 (and now under injunction) to
set FULs based on lowest AMP; we asked the agency
to direct states to adjust their Medicaid brand
name drug reimbursements to reflect the upcoming
First Data Bank AWP settlement; and we asked them
to approve state plan amendments for those states
that choose to keep "pharmacies whole" as a result
of the FDB settlement.
To date, Texas, is the
only SPA that has been approved!
The
AMP Coalition, of which NCPA is a member, sent a
letter to the Bipartisan Congressional Leadership
urging them to take immediate action to prevent
CMS from implementing these cuts once the
moratorium expires Sept. 30, 2009. However, we have no
indication that CMS is developing another AMP
regulation. We believe that they are waiting for
Congress to act on AMP changes before issuing a
new regulation.
DME accreditation
exemption and deadline
extension NCPA meets today with
CMS acting administrator Charlene Frizzera in an
effort to get a deadline extension either through
Congressional action or through action by
CMS.
NCPA continues work with the
offices of Reps. Space (D-OH), Berry (D-AR), Moran
(R-KS) and Emerson (R-MO) to push through
legislation that would extend the accreditation
and surety deadline from Oct. 1, 2009 for three
months until Jan. 1, 2010. The intent is to extend
the time until health care reform legislation can
be passed. Senators Grassley (R-IA) and Tester
(D-MT) also are helping with this issue.
In addition to the House health reform
bill action, which exempts pharmacies from DMEPOS
accreditation if they only sell crutches, canes
and diabetes supplies, the Baucus bill includes an
accreditation exemption for small pharmacies.
Pharmacies whose Medicare DMEPOS billings are less
than 5 percent of their total pharmacy sales would
be exempt.
The Baucus bill also
includes:
- a PhRMA discount
program for brand name drugs covered in the Part
D "donut hole,"
- a state-based system
of "co-ops" to provide a health insurance option
to individuals who do want or are unable to
obtain coverage from the private insurance
marketplace, and
- multiple opportunities for pharmacies to
provide patient care services as part of a
reformed health care system, such as through
accountable care organizations. Pay attention to
these opportunities. They reflect the
pharmacist's role in the health care continuum
and offer additional enterprise-building
activities.
PBM
transparency NCPA is working with
Senator Maria Cantwell (D-WA) to attach PBM
transparency language through an amendment to the
Baucus bill. The transparency language is similar
to that included in the House Energy and Commerce
health care reform bill and reflects language
proposed by NCPA.
Stay
tuned!
 Richard E. Beck,
RPh Executive Director,
Texas Pharmacy Business
Council
|
 |
Efforts
continue on FSA card issues
|
Many of our
members are calling about problems they're having
trying to process FSA cards under the '90 percent
exception" rule. The challenge is that third party
administrators and plan sponsors do not have to
process the cards, that their recognition of the
'90 percent exception" rule is
"optional!"
NCPA senior staff met for
almost two hours Friday with representatives of
the U.S. Treasury Department and IRS discussing
the FSA cards and asking them to consider revising
their position and make it clear to TPAs and plan
sponsors that pharmacies certified under the 90
percent option are able to process these cards
like those pharmacies that use IIAS systems. There
should be no discrimination against independent
pharmacies.
While not committing, they
appeared to be open to looking at options that
might enhance pharmacy participation with these
FSA cards. The Treasury and IRS staff told NCPA
they believe plans may not be allowing FSA
transactions under the 90 percent option because
pharmacies are unable to substantiate those
transactions at the POS, and the plan's insistence
to collect the more burdensome paper verification
from the enrollees using cards.
NCPA is
considering various options to enable independent
pharmacies to serve their patients who have FSA
cards. But they're not stopping with the staff
discussion, they're also considering a
Congressional approach to this issue.
|
 |
FTC
paying attention to CVS/Caremark complaints
|
The information you are
submitting about CVS Caremark anti-competitive and
anti-consumer practices is beginning to make an
impression on the Federal Trade
Commission.
NCPA senior staff and
outside counsel met this past week with the FTC
legal team that is reviewing the CVS Caremark
merger. They presented the mounting evidence
regarding the merged company's egregious
practices.
They urged pharmacists
continue collecting evidence of these types of
practices that might be occurring. Please
e-mail or fax to Texas
Pharmacy Business Council at 512-992-1391. We can
use this information in our ongoing efforts on the
state level, and we'll forward to the appropriate
people at NCPA.
Stories from your
patients' perspective are particularly compelling.
Please visit with your patients who are having or
have had problems with CVS Caremark and ask if
they would tell their story. Offer to help them
tell the story, perhaps while they are in your
pharmacy, and you can help them with writing it up
on a computer and send to
TPBC.
We are optimistic and so
is NCPA that the FTC is looking closely at this
merger and the evidence that we are presenting to
them. |
 |
HHS
urged to modify HIT regulations
|
The National
Community Pharmacists Association is asking the
Health and Human Services Office for Civil Rights
to modify regulations of the HITECH Act privacy
provisions' affects on community pharmacists'
business practices.
They sent a letter
offering suggestions to ensure approximately
23,000 community pharmacies across America are not
crippled by time-consuming and expensive
bureaucratic hurdles in order to be in compliance
with the HITECH Act. Without these suggested
modifications millions of community pharmacy
patients, especially in underserved rural and
urban communities, could see their access to
prescription drug services limited.
Issues
addressed in the letter include:
- Accounting of
disclosures
- Patient requested restrictions
on disclosures
- Business associates and updated
agreements
- Prohibition on payment for
exchange of data
- New enforcement
provisions
The entire letter
is available
for download.
| |
| |
Texas
Pharmacy Business Council Ensuring patient access to
quality pharmacy care services, the viability of
community pharmacy and the pharmacy
profession. 1001
Congress Ave., Suite 250, Austin, TX 78701
512.992.1219 Richard
E. Beck,
RPh, Executive Director www.TxRxCouncil.org | | |